{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:33:15Z","timestamp":1762144395315,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.vascn.2005.03.003","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T08:03:50Z","timestamp":1118822630000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cardiovascular parameters in anaesthetized guinea pigs: A safety pharmacology screening model"],"prefix":"10.1016","volume":"52","author":[{"given":"Daniela S.","family":"Hauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Stade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2005.03.003_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(92)90163-X","article-title":"The effect of calcium channel modulators on blood pressure and pressure responses to noradrenaline in the guinea pig","volume":"218","author":"Bond","year":"1992","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/bbrc.1994.1922","article-title":"The novel class III antiarrhythmics NE-10064 and NE10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes","volume":"202","author":"Busch","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.vascn.2005.03.003_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656566.1.5.947","article-title":"Drugs that prolong QT interval as an unwanted effect: Assessing their likelihood of inducing hazardous cardiac dysrrhythmias","volume":"1","author":"Cavero","year":"2000","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.vascn.2005.03.003_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(02)00438-8","article-title":"Effects of sildenafil on cardiac repolarization","volume":"55","author":"Chiang","year":"2002","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2005.03.003_bib5","first-page":"139","article-title":"Normal electrocardiogram in guinea pig","volume":"37","author":"Cieslar","year":"1986","journal-title":"Acta Physiologica Polonica"},{"year":"1997","series-title":"The assessment of the potential for QT prolongation by non-cardiovascular medicinal products. CPMP 986\/96","author":"CPMP (Committee for Proprietary Medicinal Products)","key":"10.1016\/j.vascn.2005.03.003_bib6"},{"key":"10.1016\/j.vascn.2005.03.003_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1472-8206.2002.00081.x","article-title":"In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: Application to the preclinical cardiovascular safety pharmacology of a new chemical entity","volume":"16","author":"De Clerck","year":"2002","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10641969409067952","article-title":"Chronic monitoring of cardiovascular function in the conscious guinea pig using radio-telemetry","volume":"16","author":"DePasquale","year":"1994","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.vascn.2005.03.003_bib9","series-title":"Abstracts from the 3rd safety pharmacology society meeting. Noordwijk, The Netherlands, September 2003","first-page":"222","article-title":"Anesthetized guinea-pig model reliably assess HERG-blocking drugs","volume":"vol. 49","author":"Drouin","year":"2004"},{"key":"10.1016\/j.vascn.2005.03.003_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-2828(89)90859-6","article-title":"Inter-species variations in myocardial responsiveness to cardiac glycosides: Possible relations to the thyroid status","volume":"21","author":"Felzen","year":"1989","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.vascn.2005.03.003_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.12.028","article-title":"Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig","volume":"486","author":"Fossa","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002018-199921001-00006","article-title":"Effects of H1 antihistamines on animal models of QTc prolongation","volume":"21","author":"Gras","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2005.03.003_bib13","unstructured":"Guidance for industry. (2001, July). ICH S7A safety pharmacology studies for human pharmaceuticals. U.S. Department of Health and Human Services, Food and Drug Administration (www.fda.gov\/cber\/guidelines.htm) ICH."},{"key":"10.1016\/j.vascn.2005.03.003_bib14","unstructured":"Guidance for industry. (2004, June). ICH S7B Step 2 Revision. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. U.S. Department of Health and Human Services, Food and Drug Administration (www.fda.gov\/cber\/guidelines.htm) ICH."},{"key":"10.1016\/j.vascn.2005.03.003_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2004.02.006","article-title":"Developing a strategy for the nonclinical assessment of proarrythmic risk of pharmaceuticals due to prolonged ventricular repolarization","volume":"49","author":"Guth","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2005.03.003_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.2042-7158.1996.tb05944.x","article-title":"The in-vivo cardiovascular effects of a putative class III antiarrhythmic drug, AM 92016","volume":"48","author":"Hagerty","year":"1996","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/toxsci\/kfg254","article-title":"QT and RR intervals in conscious and anaesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles","volume":"76","author":"Hamlin","year":"2003","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2005.03.003_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0008-6363(00)00310-2","article-title":"Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: Results of an international survey","volume":"49","author":"Hammond","year":"2001","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2005.03.003_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8719(94)90088-4","article-title":"Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates","volume":"32","author":"Hayes","year":"1994","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2005.03.003_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1474-8673.1995.tb00344.x","article-title":"Hypotensive effect of an M2-selective muscarinic antagonist in anaesthetized guinea-pigs","volume":"15","author":"Howell","year":"1995","journal-title":"Journal of Autonomic Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib21","unstructured":"Japanese guidelines for nonclinical studies of drugs manual (1995). Editorial Supervision by Pharmaceutical and Cosmetics Division; Pharmaceutical Affairs Bureau, Japanese Ministry of Health and Welfare. Yakuji Nippo, Ltd."},{"key":"10.1016\/j.vascn.2005.03.003_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0773.2001.890206.x","article-title":"Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats","volume":"89","author":"Kii","year":"2001","journal-title":"Pharmacology and Toxicology"},{"key":"10.1016\/j.vascn.2005.03.003_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2042-7158.1989.tb06435.x","article-title":"Comparative effects of ouabain on isolated papillary muscle from tree shrews, guinea-pigs and rats","volume":"41","author":"Koga","year":"1989","journal-title":"Journal of Pharmacy and Pharmacology"},{"article-title":"Electrophysiological characterization of 22 drugs in isolated guinea pig papillary muscles (JPMA QT PRODACT)","year":"2003","author":"Komeno","key":"10.1016\/j.vascn.2005.03.003_bib24"},{"key":"10.1016\/j.vascn.2005.03.003_bib25","first-page":"102","article-title":"Biphasic positive inotropic actions of ouabain on rat, guinea-pig and cat heart: A mathematical description","volume":"79","author":"Koomen","year":"1984","journal-title":"Basic Research in Cardiology. Supplement"},{"article-title":"In vitro and in vivo studies to examine the potential for compounds to prolong QT interval\u2014quintiles experience","year":"2003","author":"Landsdell","key":"10.1016\/j.vascn.2005.03.003_bib26"},{"key":"10.1016\/j.vascn.2005.03.003_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(93)90824-2","article-title":"Inhibition of Na+\/Ca2+ overload with R56865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs","volume":"235","author":"Lu","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-199507000-00021","article-title":"Antifibrillary action of class I\u2013IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs","volume":"26","author":"Lu","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib30","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1248\/bpb.22.1341","article-title":"Pharmacokinetic\/pharmacodynamic analysis of tacrolimus induced QT prolongation in guinea pigs","volume":"22","author":"Minematsu","year":"1999","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.vascn.2005.03.003_bib31","doi-asserted-by":"crossref","first-page":"PL197","DOI":"10.1016\/S0024-3205(99)00396-3","article-title":"Sustained QT prolongation induced by tacrolimus in guinea pigs","volume":"65","author":"Minematsu","year":"1999","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2005.03.003_bib32","series-title":"Abstracts from the 3rd Safety pharmacology society meeting, Noordwijk, The Netherlands, September 2003","first-page":"224","article-title":"Comparison of the sensitivity between canine telemetry assay and isoflurane-anesthetized model (JPMA QT Product)","volume":"vol. 49","author":"Miyazaki","year":"2004"},{"key":"10.1016\/j.vascn.2005.03.003_bib33","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","article-title":"Torsades des pointes occurring in association with terfenadine use","volume":"264","author":"Monahan","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.vascn.2005.03.003_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005344-199501000-00006","article-title":"Terfenadine increases the QT interval in isolated guinea pigs heart","volume":"25","author":"Pinney","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1476-5381.1996.tb15511.x","article-title":"Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig","volume":"118","author":"Roccon","year":"1996","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(91)90018-L","article-title":"Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias","volume":"209","author":"Salinas","year":"1991","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1056-8719(00)00101-5","article-title":"Continuous assessment of multiple vital physiological functions in conscious freely moving rats using telemetry and a plethysmography system","volume":"43","author":"Schierock","year":"2000","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2005.03.003_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1749-6632.1983.tb53483.x","article-title":"Anesthetic and analgesic considerations in the experimental animal","volume":"406","author":"Soma","year":"1983","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.vascn.2005.03.003_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0022-3565(25)20681-4","article-title":"Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts","volume":"278","author":"Sosunov","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2005.03.003_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2003.12.005","article-title":"The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig","volume":"486","author":"Szilagyi","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jat.975","article-title":"QT prolongation in anaesthetized guinea-pigs: An experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates","volume":"24","author":"Testai","year":"2004","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.vascn.2005.03.003_bib44","first-page":"1084","article-title":"Effect of B-HT 920 on cardiotoxic effects of ouabain in guinea pigs","volume":"29","author":"Thomas","year":"1991","journal-title":"Indian Journal of Experimental Biology"},{"key":"10.1016\/j.vascn.2005.03.003_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1476-5381.1986.tb10271.x","article-title":"Effects of \u03b1-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig","volume":"89","author":"Thomas","year":"1986","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib46","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1365-2036.1999.00655.x","article-title":"Review article: Cardiac adverse effects of gastrointestinal prokinetics","volume":"13","author":"Tonini","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2005.03.003_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.1988.tb11458.x","article-title":"Effect of some non-steriodal anti-inflammatory drugs on ouabain induced arrhythmias in guinea pigs","volume":"93","author":"Tripathi","year":"1988","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2005.03.003_bib48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0024-3205(89)90459-1","article-title":"Cardiac glycoside toxicity in small laboratory animals","volume":"44","author":"Weinhouse","year":"1989","journal-title":"Life Sciences"},{"year":"1998","series-title":"Handbook of animal management and welfare","author":"Wolfensohn","key":"10.1016\/j.vascn.2005.03.003_bib49"},{"key":"10.1016\/j.vascn.2005.03.003_bib50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.104.066100","article-title":"Antiarrhythmic effects of randolazine in a guinea pig in vitro model of long-QT syndrome","volume":"310","author":"Wu","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871905000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871905000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:50:15Z","timestamp":1761004215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871905000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1056871905000432"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2005.03.003","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular parameters in anaesthetized guinea pigs: A safety pharmacology screening model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2005.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}